- Drucker J, Soula G, Diallo O, Fabre P. Evaluation of new combined inactivated DTP-polio vaccine. Dev Biol Stand 1985; 65: 145–51.
- Cherry JD. Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials. Pediatr Infect Dis J 1997; 16: S90–6.
- Decker MD, Edwards KM, Steinhoff MC, Rennels MB, Pichichero ME, Englund MC, et al. Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics 1995; 96: 557–66.
- Bogaerts H, Capiau C, Hauser P, Mareschal J-C, Melot V, Simons D. Overview of the clinical development of a diphtheria-tetanus-acellular pertussis vaccine. J Infect Dis ; 174 Suppl 1996; 3: S276–80.
- Edwards KM, Decker MD. Combination vaccines consisting of acellular pertussis vaccines. Pediatr Infect Dis J 1997; 16: S97–S102.
- Halperin SA, Langley JM, Eastwood BJ. Effect of inactivated poliovirus vaccine on the antibody response to Bordetella pertussis antigens when combined with diphtheria-pertussis-tetanus vaccine. Clin Infect Dis 1996; 22: 59–62.
- Camargo ME, Silveira L, Furuta JA, Oliveira EPT, Germek OA. Immunoenzymatic assay of anti-diphtheria toxin antibodies in human serum. J Clin Microbiol 1984; 20: 772–4.
- Melville-Smith ME, Seagroatt VA, Watkins JT. A comparison of an enzyme-linked immunosorbent assay (ELISA) with the toxin neutralisation test in mice as a method for thestimation of tetanus antitoxin in human sera. J Biol Stand 1983; 11: 137–44.
- Melville-Smith ME, Balfour A. Estimation of Corynebacterium diphtheriae antitoxin in human sera: a comparison of an enzyme-linked immunosorbent assay with the toxin neutralization test. J Med Microbiol 1988; 25: 279–83.
- Granström M, Thoren M, Tiru M, Sato Y. Acellular pertussis vaccine in adults: adverse reactions and immune response. Eur J Clin Microbiol 1987; 6: 18–21.
- Kanra G, Ceyhan M, Bogaerts H, Vandervoode D. Acellular pertussis vaccine containing separately purified PT, FHA and 69 kDa OMP as a booster in children. Eur J Pediatr 1993; 152: 478–83.
- Karpinsky KF, Hayward S, Tryphonas H. Statistical considerations in the quantitation of serum immunoglobulin levels using the enzyme-linked immunosorbent assay (ELISA). J Immunol Methods 1987; 103: 189–94.
- Standard Procedure for determining immunity to poliovirus using the microneutralization test (WHO/EPI/Gen 93.3)
- Halperin SA, Barreto L, Eastwood BJ, Medd L, Guasparine R, Mills E. Safety and immunogenicity of an acellular pertussis diphtheria tetanus vaccine given as a single injection with Haemophilus influenzae b conjugate vaccine. Vaccine 1997; 15: 295–300.
- Eskola J, Olander R-M, Hovi T, Litmanen L, Peltola S, Käythy H. Randomized trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine. Lancet 1996; 348: 1688–92.
- Lagos R, Kotloff K, Hoffenbach A, San Martin O, Abrego P, Ureta AM, et al. Clinical acceptability and immunogenicity of pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four-and six-month-old Chilean infants. Ped Infect Dis J 1998; 17: 294–304.
- Schmitt HJ, Bautel K, Schuind A, Knuf M, Wagner S, Muschenborn S, et al. Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight month of age. J Pediatr 1997; 130: 616–23.
- Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996; 334: 349–55.
- Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, Anemona A, et al. A controlled trial of two acellular vaccines and whole-cell vaccine against pertussis. N Engl J Med 1996; 334: 341–8.
- Halperin SA, Mills E, Barreto L, Pim C, Eastwood BJ. Acellular pertussis vaccine as a booster dose for seventeen-to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J 1995; 14: 792–7.
- Blennow M, Granström M. Adverse reactions and serologic response to a booster dose of acellular pertussis vaccine in children immunized with acellular or whole-cell vaccine in infants. Pediatrics 1989; 84: 62–7.
- Englund JA, Decker MD, Edwards KM, Pichichero ME, Steinhoff MC, Anderson EL. Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study. Pediatrics 1994; 93: 37–43.
- Bodda A, Bona G, Cianciani G, Pistilli AMC, Contu B, Furlan R, et al. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen-to twenty-one-month old children. J Pediatr 1995; 127: 238–43.
- Deloria MA, Blackwelder WC, Decker MD, Englund JA, Steinhoff MC, Pichichero E, et al. Association of reactions after consecutive acellular or whole-cell pertussis vaccine immunization. Pediatrics 1995; 96: 592–4.
Scandinavian Journal of Infectious Diseases
Volume 31, 1999 - Issue 6